BNP Paribas Financial Markets
EIKN

BNP Paribas Financial Markets’s Eikon Therapeutics EIKN Stock Holding History

BNP Paribas Financial Markets’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
+8,509
New +$86.9K ﹤0.01% 4491

Other funds holding EIKN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BNP Paribas Financial Markets's EIKN Position: Q2 2026 in Review

BNP Paribas Financial Markets opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 8,509 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #4491 among its holdings.

43 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.

  • BNP Paribas Financial Markets held 8,509 shares of Eikon Therapeutics worth $111K as of Q2 2026.
  • Eikon Therapeutics was a new BNP Paribas Financial Markets position in Q2 2026.
  • Eikon Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4491 holding.
  • 43 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.